Securities code: 002422 securities abbreviation: Sichuan Kelun Pharmaceutical Co.Ltd(002422) Announcement No.: 2022-004 Sichuan Kelun Pharmaceutical Co.Ltd(002422)
Reply to the letter on the preparations for the meeting of the issuance and Examination Committee for public issuance of convertible bonds
The board of directors does not guarantee that the information disclosed by the company is true, complete or misleading.
Sichuan Kelun Pharmaceutical Co.Ltd(002422) (hereinafter referred to as "the company" or "the company") recently received the letter on making preparations for the meeting of the issuance and Examination Committee of Sichuan Kelun Pharmaceutical Co.Ltd(002422) public issuance of convertible bonds (hereinafter referred to as "notification letter") issued by China Securities Regulatory Commission (hereinafter referred to as "CSRC"). In accordance with relevant requirements, the company and relevant intermediaries have carefully studied, verified and replied to the issues involved in the notification letter. For details, see the company's designated information disclosure media cninfo.com.cn on the same day Reply to the letter on making preparations for the Sichuan Kelun Pharmaceutical Co.Ltd(002422) public offering of convertible bonds issuance and examination committee meeting disclosed on the.
The company's public offering of convertible corporate bonds still needs the approval of the CSRC, and there is uncertainty about whether it can be approved and the time of final approval. The company will fulfill the obligation of information disclosure in time according to the review progress of the CSRC. Please pay attention to the investment risks.
It is hereby announced.
Sichuan Kelun Pharmaceutical Co.Ltd(002422) board of directors January 10, 2022
